Post-GLP-1 Digital and Meal Support Curb Weight Regain: Study
A trial of 39 adults found those who used a digital wellness app or tailored meal support regained less weight after stopping GLP-1 obesity drugs than those on usual care.
Adults who stopped taking GLP-1 obesity drugs regained less weight over four months if they received a digital health program or tailored meal support rather than usual care, according to a randomized clinical trial reported by etnews.com.
The trial tracked 39 adults for four months after they stopped GLP-1 treatment. Participants were divided into three groups: usual care, a digital wellness app, and tailored meal support.
After four months, the usual care group gained an average of 10.75% of body weight, while the digital app group gained 3.60% and the tailored meal support group 3.58%.
No significant differences between the groups were found in diet quality, subjective health status, treatment adherence or satisfaction.
Background
Participants had lost an average of 18.1% of body weight while on GLP-1 therapy and joined the study within 30 days of stopping the medication. The digital program asked participants to log meals, exercise and weight and provided guidance on coping with appetite triggers. The meal support group received 10 meals a week rich in vegetables and low in saturated fat and sodium. The results were published in the journal Obesity Science and Practice.
Quick answers
How much weight did participants regain after stopping GLP-1 drugs?
After four months, the usual care group gained an average of 10.75% of body weight, compared with 3.60% in the digital app group and 3.58% in the tailored meal support group.
Where was the study published?
The results were published in the journal Obesity Science and Practice.